Losing weight can often seem like an uphill battle, especially if you're trying to get rid of stubborn abdominal fat that ...

Insulet’s stock price target has recently been raised, with the fair value estimate increasing from $366 to $378 following the company's Investor Day and updated outlook. This change reflects ...

Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against Alzheimer’s.

First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global ...

A common hot beverage costing a mere 4p could "mimic" the effects of weight loss medication, suggests recent findings.

“The human body absorbs allulose but instead of breaking it down for energy, it eliminates most of it unchanged via waste.

Type 2 diabetes, a disease in which your body cannot make enough insulin or does not properly use the insulin it makes, ...

Eli Lilly posts 54% revenue growth, raises guidance, and drives innovation in obesity and diabetes care. Read here for an ...

While Novo Nordisk and Pfizer intensify their plays, Lilly’s early lead in GLP-1 treatments has put it in a category all its ...

According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...

Ultra-processed foods are convenient choices, but they have a negative impact on your health. Learn what they are and how to make healthier choices.

About 4 in 10 of the more than 42 million Americans who get Supplemental Nutrition Assistance Program benefits are children ...